HCID 136385190, compound → HCID 77272903, compound
Reaction equation
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:9]=[CH:10][C:11]3[N:15]=[C:14]([C:16]4[C:28]5[C:27]6[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=6)[C:21](=[N:29]O)[C:20]=5[CH:19]=[CH:18][CH:17]=4)[NH:13][C:12]=3[CH:31]=2)[CH2:4][CH2:3]1>[Ni].C(O)C.O1CCCC1>[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:9]=[CH:10][C:11]3[N:15]=[C:14]([C:16]4[C:28]5[C:27]6[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=6)[CH:21]([NH2:29])[C:20]=5[CH:19]=[CH:18][CH:17]=4)[NH:13][C:12]=3[CH:31]=2)[CH2:4][CH2:3]1Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Procedure
The procedure used in Example 6 is followed, but starting from 1.5 g of 4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-9H-fluoren-9-one oxime (Z,E), obtained in the previous stage, and 229 mg of Raney nickel in 35 ml of ethanol and 35 ml of tetrahydrofuran for 48 hours at 60° C. under an initial hydrogen pressure of one bar. After filtration of the catalyst, concentration to dryness under reduced pressure and purification by formation of a paste in diisopropyl ether, in this way we obtained 1.3 g of 4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-9H-fluoren-9(R,S)-ylamine, in the form of an orange powder, which is used as it is in the following stage, with the following characteristics:
Workup
- filtrationAfter filtration of the catalyst, concentration to dryness
- customunder reduced pressure and purification by formation of a paste in diisopropyl ether
Sources & evidence
- ORD record
- ord-1fdea72639ce4d24b562140a23ea937c
- Source dataset
- uspto-grants-2010_03
- Patent number
- US07674795B2
Reaction notes
Loading…